CapsoVision Inc. Common Stock
Financials
Valuation Metrics
CapsoVision Inc. Common Stock's Market Cap is $335M. At end of 2025 it was $501M. Ranked #2932 of 3,121 in US market (top 94%), #1320 of 1,463 on NASDAQ (top 90%), #241 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 91%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $335M | US#2,932/3,121 Sec#241/266 |
| Revenue | $14M | US#2,825/3,121 Sec#168/266 |
| Net Income | $-30M | US—/3,121 Sec—/266 |
| Total Assets | $19M | US#3,093/3,121 Sec#267/266 |
| Net Assets | $13M | US#2,905/3,121 Sec#237/266 |
| Employees | 99 | US#2,634/3,121 Sec#181/266 |
| Value | ||
| P/B | 25.43x | US#2,823/3,121 Sec#224/266 |
| P/S | 24.10x | US#2,864/3,121 Sec#147/266 |
| FCF Yield | -8.33% | US—/3,121 Sec—/266 |
| Profitability | ||
| Op. Margin | -158.64% | US#2,763/3,121 Sec#132/266 |
| Revenue Growth | 10.99% | US#1,190/3,121 Sec#95/266 |
| Financial Health | ||
| Debt Ratio | 41.04% | US#468/3,121 Sec#130/266 |
| Total Debt | $687000.00 | US#2,994/3,121 Sec#249/266 |
| FCF | $-28M | US#2,463/3,121 Sec#100/266 |
| Cash | $9M | US#2,984/3,121 Sec#264/266 |
| Current Ratio | 3.35x | US#695/3,121 Sec#179/266 |
| Dividend | ||
| Div. Yield | 0.00% | US#1,746/3,121 Sec#27/266 |
| Performance | ||
| 1Y Return | 44.40% | US#770/3,121 Sec#126/266 |
| 1M Return | 9.48% | US#639/3,121 Sec#66/266 |
| From 52W High | -56.41% | US#2,898/3,121 Sec#234/266 |
| 1Y MDD | -67.82% | US#2,923/3,121 Sec#233/266 |
| Trading | ||
| Volume | 1,192,841 shares | US#2,715/3,121 Sec#254/266 |
| Trading Value | $8M | US#3,001/3,121 Sec#256/266 |
| Per Share | ||
| EPS | $-0.60 | US—/3,121 Sec—/266 |
| BPS | $0.26 | US#2,789/3,121 Sec#228/266 |
Company Info
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.